A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomasSeung Ju Kim, Woo Seob Kim, Young-Rok Do et al.|Annals of Oncology|2016Cited by 54
Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01Jung Hye Choi, Seok-Hyun Kim, Tae Min Kim et al.|Cancer Research and Treatment|2017Cited by 13
Diffuse large B-cell lymphoma in very elderly patients older than 80 years: A multicenter retrospective analysis of clinical characteristics, treatment patterns, and outcome—KCSG LY16-01.Jung Hye Choi, Yun Hwa Jung, Young Jin Yuh et al.|Journal of Clinical Oncology|2017Cited by 0